Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Medibank Private Limited
  6. News
  7. Summary
    MPL   AU000000MPL3

MEDIBANK PRIVATE LIMITED

(MPL)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Medibank May Benefit From Surgery Business Investment

07/21/2021 | 10:03pm EDT

Australian private-health insurer Medibank's new no-gap, short stay surgery business should drive industry efficiencies and strong earnings per share growth, says Morgan Stanley. Medibank has so far invested A$200 million into healthcare businesses and the appeal of its strategy looks under appreciated by investors, the investment bank says. Medibank's stock may in fact warrant a premium as its healthcare presence grows. Rival health insurer Nib and healthcare provider Ramsay Health Care are trying to develop the same approach, but are at an earlier stage than Medibank, Morgan Stanley says. (alice.uribe@wsj.com)

(END) Dow Jones Newswires

07-21-21 2202ET

Stocks mentioned in the article
ChangeLast1st jan.
MEDIBANK PRIVATE LIMITED 0.56% 3.57 End-of-day quote.18.60%
NIB HOLDINGS LIMITED -0.87% 6.8 End-of-day quote.13.90%
RAMSAY HEALTH CARE LIMITED -0.75% 69.26 End-of-day quote.11.39%
All news about MEDIBANK PRIVATE LIMITED
09/22MEDIBANK PRIVATE : 450,000 reasons to say thanks
PU
09/21NIB : Honeysuckle Health, nib buying group authorised with condition
AQ
09/20MEDIBANK PRIVATE : No-gap endoscopy now available to Sydney customers
PU
09/18MEDIBANK PRIVATE : Creating a sustainable future – a look back on FY21
PU
09/17Scientific Games seeks $5 bln lotteries unit IPO in Australia - sources
RE
09/16MEDIBANK PRIVATE : Notice of Annual General Meeting 2021 (PDF - 1,404 KB)
PU
09/16MEDIBANK PRIVATE : Virtual meeting guide (PDF - 291 KB)
PU
09/16Medibank Private Limited Announces Consolidated Earnings Results for the Year Ended Jun..
CI
09/16Medibank Private Limited Announces Board Resignations, Effective 18 November 2021
CI
08/25MEDIBANK PRIVATE : FY21 Results - Appendix 4E and Financial Report
PU
More news
Financials
Sales 2022 7 278 M 5 282 M 5 282 M
Net income 2022 431 M 313 M 313 M
Net cash 2022 2 176 M 1 580 M 1 580 M
P/E ratio 2022 22,9x
Yield 2022 3,60%
Capitalization 9 835 M 7 127 M 7 138 M
EV / Sales 2022 1,05x
EV / Sales 2023 0,99x
Nbr of Employees 3 409
Free-Float 99,4%
Chart MEDIBANK PRIVATE LIMITED
Duration : Period :
Medibank Private Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIBANK PRIVATE LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 3,57 AUD
Average target price 3,56 AUD
Spread / Average Target -0,35%
EPS Revisions
Managers and Directors
David Koczkar Chief Executive Officer & Managing Director
Mark Rogers Chief Financial Officer & Group Strategy Officer
Michael Wilkins Chairman
John Goodall Group Executive-Technology & Operations
Anna Bligh Independent Non-Executive Director
Sector and Competitors